EU regulators have decided to update and extend to 2028 their existing five-year strategy, which contains detailed work plans for key priority areas and was originally scheduled to run until the end of 2025.
The European Medicines Agency said that the strategy would now include two new topics: artificial intelligence and how to improve...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?